Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial host cell lysis is the process by which bacterial cells are destroyed, releasing their intracellular contents into the environment. This often occurs during viral (bacteriophage) infection when specialized enzymes (endolysins/lysins) degrade the cell wall peptidoglycan and membrane proteins (holins) permeabilize the cytoplasmic membrane, allowing these enzymes to access their substrate and trigger rapid cell death and lysis[1][2][3]. In some bacteria, lysis is also mediated or regulated by bacterial autolysin systems, prophage elements, or in response to external stressors such as antibiotics or DNA-damaging agents. The event is central to bacteriophage replication (to release viral particles) and plays a role in bacterial population dynamics, biofilm structure, and host-pathogen interactions. Because "bacterial host cell lysis" is not a discrete molecular entity, but represents a process, it is not categorized as a receptor, enzyme, or canonical drug target[1][2][3][4].
Induction of lysis via bacterial cell wall degradation (endolysin, lysins) Membrane permeabilization via holins Autolysin activation in bacteria
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial host cell lysis.